Holen Sie sich die Stockscreener-App
27.19
4.04%
1.07
Schlusskurs vom Vortag:
$26.12
Offen:
$26.12
24-Stunden-Volumen:
1.01M
Relative Volume:
0.65
Marktkapitalisierung:
$1.53B
Einnahmen:
$308.05M
Nettoeinkommen (Verlust:
$-95.57M
KGV:
-15.81
EPS:
-1.72
Netto-Cashflow:
$-58.34M
1W Leistung:
+12.20%
1M Leistung:
-2.21%
6M Leistung:
-26.83%
1J Leistung:
-51.50%
1-Tages-Spanne:
$26.00
$27.39
1-Wochen-Bereich:
$23.31
$27.87
52-Wochen-Spanne:
$19.35
$66.85
Procept Biorobotics Corp Stock (PRCT) Company Profile
Firmenname
Procept Biorobotics Corp
Sektor
Branche
Telefon
(650) 232-9832
Adresse
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
27.19 | 1.47B | 308.05M | -95.57M | -58.34M | -1.72 |
|
ABT
Abbott Laboratories
|
107.91 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.25 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.06 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.87 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.75 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2026-02-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2026-02-26 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-12-12 | Eingeleitet | UBS | Buy |
| 2025-12-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-09-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Eingeleitet | Stephens | Overweight |
| 2025-07-07 | Eingeleitet | Oppenheimer | Perform |
| 2024-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Eingeleitet | Jefferies | Hold |
| 2023-08-11 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-31 | Eingeleitet | William Blair | Outperform |
| 2022-10-31 | Eingeleitet | BTIG Research | Neutral |
| 2022-10-25 | Eingeleitet | Truist | Buy |
| 2022-09-02 | Eingeleitet | Wells Fargo | Overweight |
| 2022-07-15 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | Guggenheim | Buy |
| 2021-10-11 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Procept Biorobotics Corp Aktie (PRCT) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PROCEPT BioRobotics Corporation (PRCT) And Encourages Investors to Reach Out - ACCESS Newswire
Mackenzie Financial Corp Raises Stock Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics launches HYDROS system in UK By Investing.com - Investing.com India
FMR LLC Reduces Stake in PROCEPT BioRobotics Corp by 65.40% - GuruFocus
PROCEPT BioRobotics launches HYDROS system in UK - Investing.com South Africa
Insider Selling: PROCEPT BioRobotics (NASDAQ:PRCT) EVP Sells 3,243 Shares of Stock - MarketBeat
Procept BioRobotics announces international Hydros robot launch - MassDevice
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PROCEPT BioRobotics Corporation (PRCT) And Encourages Stockholders to Reach Out - ACCESS Newswire
Procept BioRobotics announce international launch of HYDROS Robotic - TipRanks
Procept Biorobotics Announces International Launch of the Hydros Robotic System, Expanding Global Access to Ai-Enabled Aquablation Therapy - marketscreener.com
PROCEPT BioRobotics Overcomes S-Curve Challenge as HYDROS Seeks Rapid Expansion of BPH Treatments - Bitget
PROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 7.2%Time to Buy? - MarketBeat
PRCT: $50.2M ADJUSTED EBITDA LOSS VS. $35M PROJECTED -- LEVI & KORSINSKY, LLP INVESTIGATES - marketscreener.com
PROCEPT BioRobotics Corporation (PRCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
[144] PROCEPT BioRobotics Corp SEC Filing - Stock Titan
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - The AI Journal
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - Benzinga
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap Up on Insider Buying Activity - MarketBeat
Is PROCEPT’s Growth Targets And New CFO Director Altering The Investment Case For PROCEPT BioRobotics (PRCT)? - simplywall.st
Major Insider Shake-Up at PROCEPT BioRobotics as Top Executives Trade Shares - TipRanks
Procept Biorobotics director Desai buys PRCT shares worth $10.4m By Investing.com - Investing.com Nigeria
Procept Biorobotics director Desai buys PRCT shares worth $10.4m - Investing.com
Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
PROCEPT BioRobotics (NASDAQ:PRCT) Director Antal Rohit Desai Purchases 167,246 Shares - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Director Buys $3,781,878.03 in Stock - MarketBeat
Insider Buying: PROCEPT BioRobotics (NASDAQ:PRCT) Director Acquires 98,699 Shares of Stock - MarketBeat
Kevin Waters Sells 6,721 Shares of PROCEPT BioRobotics (NASDAQ:PRCT) Stock - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) EVP Sells $163,340.40 in Stock - MarketBeat
Alaleh Nouri, EVP at Procept Biorobotics, sells $163k in shares - Investing.com India
PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm - Business Wire
PROCEPT BioRobotics Corporation $PRCT Shares Purchased by Rhenman & Partners Asset Management AB - MarketBeat
Blair William & Co. IL Purchases 169,237 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Adds Independent Director to Audit Committee - The Globe and Mail
Baird Initiates Coverage of PROCEPT BioRobotics (PRCT) with Neutral Recommendation - Nasdaq
Baird initiates Procept BioRobotics stock rating at Neutral By Investing.com - Investing.com India
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Down 6.9%Time to Sell? - MarketBeat
Baird initiates Procept BioRobotics stock rating at Neutral - Investing.com
Robert W. Baird Initiates Coverage on PROCEPT BioRobotics (NASDAQ:PRCT) - MarketBeat
Procept Biorobotics Corporation Appoints Daniel Puckett Board and Audit Committee Member, Effective March 5, 2026 - marketscreener.com
PRCT: Baird Initiates Neutral Rating with $30 Price Target | PRC - GuruFocus
Procept BioRobotics appoints Daniel Puckett to board and audit committee - Investing.com
Procept BioRobotics initiated with a Neutral at Baird - TipRanks
A Look At PROCEPT BioRobotics (PRCT) Valuation After Earnings Miss And New 2026 To 2027 Guidance - simplywall.st
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PROCEPT BioRobotics CorporationPRCT - PR Newswire
Procept BioRobotics Balances Rapid Growth With Profit Push - TipRanks
PROCEPT BioRobotics Corp. Hits New 52-Week Low at $19.35 - Markets Mojo
PROCEPT BioRobotics Stock Hits Day Low of $19.35 Amid Price Pressure - Markets Mojo
PROCEPT BioRobotics Faces Weak Start with 30.5% Gap Down Amid Market Concerns - Markets Mojo
Mitsubishi UFJ Asset Management Co. Ltd. Sells 56,967 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Champlain Investment Partners LLC Grows Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Finanzdaten der Procept Biorobotics Corp-Aktie (PRCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.70%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):